Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med. 2013, 369: 840-851. 10.1056/NEJMra1208623.
Article
CAS
Google Scholar
Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Regnier B: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA. 1995, 274: 968-10.1001/jama.1995.03530120060042.
Article
CAS
Google Scholar
Schoenberg MH, Weiss M, Radermacher P: Outcome of patients with sepsis and septic shock after ICU treatment. Langenbecks Arch Surg. 1998, 383: 44-48. 10.1007/s004230050090.
Article
CAS
Google Scholar
Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-1554. 10.1056/NEJMoa022139.
Article
Google Scholar
Fortenberry JD, Paden ML: Extracorporeal therapies in the treatment of sepsis: experience and promise. Semin Pediatr Infect Dis. 2006, 17: 72-79. 10.1053/j.spid.2006.04.005.
Article
Google Scholar
Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH: Apheresis Applications Committee of the American Society for A: Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010, 25: 83-177. 10.1002/jca.20240.
Article
Google Scholar
Stegmayr B: Apheresis in patients with severe sepsis and multi organ dysfunction syndrome. Transfus Apher Sci. 2008, 38: 203-208. 10.1016/j.transci.2008.03.009.
Article
Google Scholar
Vain NE, Mazlumian JR, Swarner OW, Cha CC: Role of exchange transfusion in the treatment of severe septicemia. Pediatrics. 1980, 66: 693-697.
CAS
Google Scholar
Bjorvatn B, Bjertnaes L, Fadnes HO, Flaegstad T, Gutteberg TJ, Kristiansen BE, Pape J, Rekvig OP, Osterud B, Aanderud L: Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J. 1984, 288: 439-441. 10.1136/bmj.288.6415.439.
Article
CAS
Google Scholar
Brandtzaeg P, Sirnes K, Folsland B: Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients. Scand J Clin Lab Invest. 1985, 45: 53-55.
Google Scholar
Drapkin MS, Wisch JS, Gelfand JA, Cannon JG, Dinarello CA: Plasmapheresis for fulminant meningococcemia. Pediatr Infect Dis J. 1989, 8: 399-400. 10.1097/00006454-198906000-00015.
Article
CAS
Google Scholar
Scharfman WB, Tillotson JR, Taft EG, Wright E: Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl J Med. 1979, 300: 1277-1278.
CAS
Google Scholar
Schmidt J, Mann S, Mohr VD, Lampert R, Firla U, Zirngibl H: Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis. Intensive Care Med. 2000, 26: 532-537. 10.1007/s001340051200.
Article
CAS
Google Scholar
Van Deuren M, Santman FW, Van Dalen R, Sauerwein RW, Span LFR, Van der Meer JWM: Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis. 1992, 15: 424-430. 10.1093/clind/15.3.424.
Article
CAS
Google Scholar
Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wikstrom B, Wretlind B: Plasmapheresis in the treatment of primary septic shock in humans. Scand J Infect Dis. 1993, 25: 757-761. 10.3109/00365549309008575.
Article
CAS
Google Scholar
Stegmayr BG: Plasma exchange in patients with septic shock including acute renal failure. Blood Purif. 1996, 14: 102-108. 10.1159/000170251.
Article
CAS
Google Scholar
Chandler J, Churchill R, Higgins J, Lasserson T, Tovey D: Methodological Expectations of Cochrane Intervention Reviews (MECIR) methodological standards for the conduct of new Cochrane Intervention Reviews, Version 2.1. The Cochrane Collaboration; 2011. [www.editorial-unit.cochrane.org/mecir]
Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009, 339: b2535-10.1136/bmj.b2535.
Article
Google Scholar
Higgins JP, Green S (Eds): Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 edition. The Cochrance Collaboration; 2011. [www.cochrane-handbook.org]
Higgins JPT, Green S (Eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration; 2008. [www.cochrane-handbook.org]
Julian PTH, Douglas GA, Peter CG, Peter JÃ, David M, Andrew DO, Jelena S, Kenneth FS, Laura W, Jonathan ACS: The Cochrane Collaboration™ tool for assessing risk of bias in randomised trials. BMJ. 2011, 343: d5928-10.1136/bmj.d5928.
Article
Google Scholar
Knaus WA, Draper EA: APACHE II: A severity of disease classification system. Crit Care Med. 1985, 13: 818-829. 10.1097/00003246-198510000-00009.
Article
CAS
Google Scholar
Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ: Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med. 1999, 27: 2096-2104. 10.1097/00003246-199910000-00003.
Article
CAS
Google Scholar
Busund R, Koukline V, Utrobin U, Nedashkovsky E: Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med. 2002, 28: 1434-1439. 10.1007/s00134-002-1410-7.
Article
Google Scholar
Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, Orr RA, Janosky J, Carcillo JA: Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008, 36: 2878-2887. 10.1097/CCM.0b013e318186aa49.
Article
CAS
Google Scholar
Long EJ, Shann F, Pearson G, Buckley D, Butt W: A randomised controlled trial of plasma filtration in severe paediatric sepsis. Crit Care Resusc. 2013, 15: 198-204.
Google Scholar
Aird WC: The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc. 2003, 78: 869-881. 10.4065/78.7.869.
Article
CAS
Google Scholar
Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent J-L, Ramsay G, SCCM/ESICM/ACCP/ATS/SIS: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003, 31: 1250-1256. 10.1097/01.CCM.0000050454.01978.3B.
Article
Google Scholar
Matthay MA: Severe sepsis – a new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med. 2001, 344: 759-762. 10.1056/NEJM200103083441009.
Article
CAS
Google Scholar
Levi M, Schultz M, van der Poll T: Coagulation biomarkers in critically ill patients. Crit Care Clin. 2011, 27: 281-297. 10.1016/j.ccc.2010.12.009.
Article
CAS
Google Scholar
Toltl LJ, Swystun LL, Pepler L, Liaw PC: Protective effects of activated protein C in sepsis. Thromb Haemost. 2008, 100: 582-592.
CAS
Google Scholar
Afshari A, Wetterslev J, Brok J, Moller A: Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. BMJ. 2007, 335: 1248-1251. 10.1136/bmj.39398.682500.25.
Article
Google Scholar
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001, 344: 699-709. 10.1056/NEJM200103083441001.
Article
CAS
Google Scholar
Esmon CT: Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?. Blood. 2000, 95: 1113-1116.
CAS
Google Scholar
Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA, Optimus Trial Study Group: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA. 2003, 290: 238-247. 10.1001/jama.290.2.238.
Article
CAS
Google Scholar
Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, Reines HD, Shelly MP, Thompson BW, LaBrecque JF, Catalano MA, Knaus WA, Sadoff JC, Phase III, rhIL-1ra Sepsis Syndrome Study Group: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA. 1994, 271: 1836-1843. 10.1001/jama.1994.03510470040032.
Article
Google Scholar
Bone RC, Balk RA, Fein AM, Perl TM, Wenzel RP, Reines HD, Quenzer RW, Iberti TJ, Macintyre N, Schein RM: A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med. 1995, 23: 994-1006. 10.1097/00003246-199506000-00003.
Article
CAS
Google Scholar
Cohen J, Carlet J: INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med. 1996, 24: 1431-1440. 10.1097/00003246-199609000-00002.
Article
CAS
Google Scholar
Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, Pennington JE, Wherry JC, TNG-alpha MAb Sepsis Study Group: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA. 1995, 273: 934-941. 10.1001/jama.1995.03520360048038.
Article
CAS
Google Scholar
Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, D’Intini V, Bellomo R: Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003, 27: 792-801. 10.1046/j.1525-1594.2003.07289.x.
Article
Google Scholar
Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991, 325: 393-397. 10.1056/NEJM199108083250604.
Article
CAS
Google Scholar
Cinel I, Opal SM: Molecular biology of inflammation and sepsis: a primer. Crit Care Med. 2009, 37: 291-304. 10.1097/CCM.0b013e31819267fb.
Article
CAS
Google Scholar
Zhou F, Peng Z, Murugan R, Kellum JA: Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013, 41: 2209-2220. 10.1097/CCM.0b013e31828cf412.
Article
CAS
Google Scholar
Livigni S, Bertolini G, Rossi C, Ferrari F, Giardino M, Pozzato M, Remuzzi G, GiViTI (Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva): Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: A multicenter randomised controlled clinical trial. BMJ Open. 2014, 4: e003536-10.1136/bmjopen-2013-003536.
Article
Google Scholar
Taori G, Ho KM, George C, Bellomo R, Webb SA, Hart GK, Bailey MJ: Landmark survival as an end-point for trials in critically ill patients – comparison of alternative durations of follow-up: an exploratory analysis. Crit Care. 2009, 13: R128-10.1186/cc7988.
Article
Google Scholar
McGee DC, Gould MK: Preventing complications of central venous catheterization. N Engl J Med. 2003, 348: 1123-1133. 10.1056/NEJMra011883.
Article
Google Scholar
Basic-Jukic N, Kes P, Glavas-Boras S, Brunetta B, Bubic-Filipi L, Puretic Z: Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial. 2005, 9: 391-395. 10.1111/j.1744-9987.2005.00319.x.
Article
Google Scholar